FR09C0006I2 - ENANTIOMERIC AMINO ACID DERIVATIVES WITH AN ANTI-CONVULSIVE EFFECT - Google Patents

ENANTIOMERIC AMINO ACID DERIVATIVES WITH AN ANTI-CONVULSIVE EFFECT

Info

Publication number
FR09C0006I2
FR09C0006I2 FR09C0006C FR09C0006C FR09C0006I2 FR 09C0006 I2 FR09C0006 I2 FR 09C0006I2 FR 09C0006 C FR09C0006 C FR 09C0006C FR 09C0006 C FR09C0006 C FR 09C0006C FR 09C0006 I2 FR09C0006 I2 FR 09C0006I2
Authority
FR
France
Prior art keywords
amino acid
acid derivatives
enantiomeric amino
convulsive effect
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR09C0006C
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Tech
Research Corp Technologies Inc
Original Assignee
Research Corp Tech
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR09C0006(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp Tech, Research Corp Technologies Inc filed Critical Research Corp Tech
Publication of FR09C0006I1 publication Critical patent/FR09C0006I1/fr
Application granted granted Critical
Publication of FR09C0006I2 publication Critical patent/FR09C0006I2/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is directed to the use of a compound in the R configuration having the formula: <CHEM> wherein Ar is phenyl which is unsubstituted or substituted with at least one halo group; Q is alkoxy containing one to six carbon atoms, and Q1 is methyl, in a method for treating central nervous system disorders in an animal comprising administering to said animal in need thereof an anticonvulsant effective amount.
FR09C0006C 1996-03-15 2009-02-26 ENANTIOMERIC AMINO ACID DERIVATIVES WITH AN ANTI-CONVULSIVE EFFECT Active FR09C0006I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15
PCT/US1997/004579 WO1997033861A1 (en) 1996-03-15 1997-03-17 Anticonvulsant enantiomeric amino acid derivatives

Publications (2)

Publication Number Publication Date
FR09C0006I1 FR09C0006I1 (en) 2009-04-17
FR09C0006I2 true FR09C0006I2 (en) 2009-12-18

Family

ID=21760388

Family Applications (1)

Application Number Title Priority Date Filing Date
FR09C0006C Active FR09C0006I2 (en) 1996-03-15 2009-02-26 ENANTIOMERIC AMINO ACID DERIVATIVES WITH AN ANTI-CONVULSIVE EFFECT

Country Status (12)

Country Link
EP (2) EP1038522B1 (en)
JP (1) JP3145414B2 (en)
AT (2) ATE268169T1 (en)
AU (1) AU718577B2 (en)
CA (1) CA2248317C (en)
DE (3) DE69729392T2 (en)
DK (2) DK0888289T3 (en)
ES (2) ES2218024T3 (en)
FR (1) FR09C0006I2 (en)
NL (1) NL300376I1 (en)
PT (2) PT1038522E (en)
WO (1) WO1997033861A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (en) 2004-10-02 2006-04-05 Schwarz Pharma Ag Improved synthesis scheme for lacosamide
EP1873527A1 (en) 2006-06-30 2008-01-02 Schwarz Pharma Ag Method for identifying CRMP modulators
US8093426B2 (en) * 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (en) 2008-11-27 2010-06-02 Ratiopharm Gmbh Dry processing and new forms of lacosamide
US8440861B2 (en) 2009-08-06 2013-05-14 Medichem, S.A. Solid forms of an N-(phenylmethyl)propanamide derivative and processes of preparation
WO2011039781A1 (en) * 2009-09-25 2011-04-07 Cadila Healthcare Limited Processes for the preparation of lacosamide and intermediates thereof
IT1398044B1 (en) * 2010-01-29 2013-02-07 Archimica Srl PROCESS FOR THE PREPARATION OF LACOSAMIDE
CA2788451A1 (en) 2010-02-08 2011-08-11 Natco Pharma Limited A process for the preparation of lacosamide
EP2534127A4 (en) 2010-02-09 2013-11-27 Msn Lab Ltd Process for preparing (r)-2-acetamido-n-benzyl-3-methoxy-propionamide
EP2399901A1 (en) 2010-06-23 2011-12-28 Archimica GmbH Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide
EP2621893A1 (en) 2010-10-01 2013-08-07 UCB Pharma GmbH Process for the preparation of amino acid derivatives
WO2012051551A1 (en) * 2010-10-15 2012-04-19 Nektar Therapeutics N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
PL2444390T3 (en) 2010-10-19 2017-06-30 Euticals Gmbh Process for producing Lacosamide
WO2012072256A2 (en) 2010-12-02 2012-06-07 Ucb Pharma Gmbh Once daily formulation of lacosamide
EP2468261A1 (en) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide
CN104771356A (en) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 Lacosamide injection and preparation method thereof
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE62222T1 (en) * 1985-02-15 1991-04-15 Res Corp Technologies Inc AMINO ACID DERIVATIVES AND THEIR APPLICATION FOR THE PREPARATION OF AN ANTI-SEMPK AGENT.
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant

Also Published As

Publication number Publication date
DE69705210T2 (en) 2001-09-20
ES2157567T3 (en) 2001-08-16
CA2248317A1 (en) 1997-09-18
PT888289E (en) 2001-09-28
DE122009000010I2 (en) 2010-10-21
CA2248317C (en) 2003-12-02
DE69705210D1 (en) 2001-07-19
AU2539497A (en) 1997-10-01
EP1038522A3 (en) 2003-01-15
DE69729392D1 (en) 2004-07-08
FR09C0006I1 (en) 2009-04-17
DK0888289T3 (en) 2001-09-03
EP1038522B1 (en) 2004-06-02
DE69729392T2 (en) 2005-06-02
PT1038522E (en) 2004-10-29
ATE202079T1 (en) 2001-06-15
EP0888289A1 (en) 1999-01-07
JP2000505476A (en) 2000-05-09
AU718577B2 (en) 2000-04-13
EP0888289B1 (en) 2001-06-13
JP3145414B2 (en) 2001-03-12
ES2218024T3 (en) 2004-11-16
ATE268169T1 (en) 2004-06-15
WO1997033861A1 (en) 1997-09-18
DK1038522T3 (en) 2004-10-11
DE122009000010I1 (en) 2009-05-20
NL300376I1 (en) 2009-05-06
EP1038522A2 (en) 2000-09-27

Similar Documents

Publication Publication Date Title
FR09C0006I2 (en) ENANTIOMERIC AMINO ACID DERIVATIVES WITH AN ANTI-CONVULSIVE EFFECT
PH31123A (en) Benzimidazole compounds.
MA23603A1 (en) OXALYLAMINO-BENZAFURAN AND BENZOTHIENYL DERIVATIVES.
FI974447A (en) Semicarbazones having central nervous system activity and pharmaceutical preparations containing them
EA199900620A1 (en) Phthalasins
DE69728544D1 (en) TOTAL SYNTHESIS OF ACYL FULVENES WITH ANTITUARY EFFECT
FI921049A (en) HYDRAZONDERIVAT, DERAS FRAMSTAELLNING OCH ANVAENDNING
IE840155L (en) Phosphorus containing carboxylic acid derivatives
ATE399545T1 (en) AGENTS FOR REDUCING EGG FAT
DE59607208D1 (en) Use of a sodium or lysinium salt of crotonic acid amide derivatives for the manufacture of a medicament for the treatment of cancer
ATE156359T1 (en) PHOSPHATE DIESTER FOR THE TREATMENT OF PROLIFERATIVE DISEASES OF THE EPIDERMIS
FI905943A (en) ISOTINDERIVAT, DERAS FRAMSTAELLNING OCH ANVAENDNING.
ES2148561T3 (en) PREVENTION AND CURE OF TYPE I ALLERGIC DISEASES.
DK498889D0 (en) SUBSTITUTED AROMATIC RELATIONS WITH EFFECT ON THE CENTRAL NERVOUS SYSTEM
EA199900888A1 (en) ANTI-RELATED MEANS
EP0555479A4 (en)
ES2138724T3 (en) N-AMIDINE DERIVATIVE OF DERMORPHINE.
ATE283269T1 (en) 5-(HETEROARYL)ALKYL)-3-OXO-PYRIDO(1,2-A)BENZIMIDAZOLE-4-CARBOXAMIDE (PBI) DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
PT88242A (en) PROCESS FOR THE PREPARATION OF ETEREYS AND THIOETERS HAVING THERAPEUTIC ACTIVITY
ES2162062T3 (en) STABILIZATION OF NITRILS.
ATE48511T1 (en) M-CYANPHENETHANOLAMINE AS ANIMAL GROWTH PROMOTER AND ANTILIPOGENIC AGENT.
MX9204939A (en) INHIBITORS 5-BIS-AMINOMETILEN-1,3-DIOXAN-4,6-DIONA N, N &#39;, N&#39;-TRISUBSTITUIDAS, DE LA ACIL COENZIMA A: CHOLESTEROL-ACILTRANSFERASA.
MX9803497A (en) Processes and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenox y-2(s)-ol.